MESO MESOBLAST LTD

Nasdaq mesoblast.com


$ 16.81 $ -0.29 (-1.7 %)    

Friday, 24-Oct-2025 15:59:53 EDT
QQQ $ 617.50 $ 6.52 (1.07 %)
DIA $ 472.45 $ 4.92 (1.05 %)
SPY $ 677.25 $ 5.49 (0.82 %)
TLT $ 91.47 $ 0.04 (0.04 %)
GLD $ 378.59 $ -1.27 (-0.34 %)
$ 16.81
$ 17.03
$ 16.76 x 1
$ 19.43 x 1
$ 16.79 - $ 17.18
$ 7.09 - $ 22.00
136,948
na
4.3B
$ 1.37
nm
TBD
na
na ($ 0.00)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
No Data found
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

 reported-sunday-mesoblast-q1-revenue-surges-to-206m-as-ryoncil-net-sales-jump-69-driven-by-wider-physician-adoption-and-reimbursement

Revenue from cell therapy products was US$20.6 million, up from US$12.9 million in the previous quarter ended June 30, 2025, an...

 mesoblast-shares-are-rising-higher-whats-behind-the-move

Mesoblast Limited (NASDAQ:MESO) shares are trading higher on Friday after the company announced that Ryoncil received a J-Code ...

 mesoblast-fy-eps-009-misses-005-estimate-sales-1720m-up-from-590m-yoy

Mesoblast (NASDAQ:MESO) reported quarterly losses of $(0.09) per share which missed the analyst consensus estimate of $(0.05) b...

 independent-bank-posts-upbeat-earnings-joins-blaize-holdings-interactive-brokers-group-and-other-big-stocks-moving-higher-on-friday

U.S. stocks were mixed, with the Dow Jones index falling around 50 points on Friday.

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION